首页 › 基金 › THOMPSON SIEGEL & WALMSLEY LLC › HSIC
THOMPSON SIEGEL & WALMSLEY LLC 对 HSIC 的持仓历史
SCHEIN HENRY INC · 医疗保健
THOMPSON SIEGEL & WALMSLEY LLC 在 Q3 2026 的 13F 申报中披露持有 HSIC(SCHEIN HENRY INC)445,254 股,市值约 US$37.4M,约占其申报组合的 0.70%,在其申报持仓中市值排名第 48 位。 THOMPSON SIEGEL & WALMSLEY LLC 最近 10 个申报季度中有 10 个季度披露了 HSIC 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
THOMPSON SIEGEL & WALMSLEY LLC 对 HSIC 的持仓演变
THOMPSON SIEGEL & WALMSLEY LLC 于 Q2 2024 首次披露 HSIC 持仓:728,285 股(约 US$46.7M)。 该持仓在 Q3 2024 达到峰值 1,003,041 股,市值约 US$73.1M。 在 10 次申报中,THOMPSON SIEGEL & WALMSLEY LLC 3 次增持、6 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 445,254 股、市值约 US$37.4M,环比减持 -260,744 股。。 持仓曾出现大幅变动:Q3 2024 增持约 38% (随后一个季度股价下跌 5%)、Q1 2025 减持约 40% (随后一个季度股价上涨 7%)、Q3 2025 增持约 40% (随后一个季度股价上涨 14%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 728.28K | $46.68M | 新进 |
| Q3 2024 | 1.00M | $73.12M | 增持 |
| Q4 2024 | 852.42K | $58.99M | 减持 |
| Q1 2025 | 513.60K | $35.18M | 减持 |
| Q2 2025 | 613.05K | $44.78M | 增持 |
| Q3 2025 | 856.55K | $56.85M | 增持 |
| Q4 2025 | 809.41K | $61.17M | 减持 |
| Q1 2026 | 805.28K | $59.35M | 减持 |
| Q2 2026 | 706.00K | $58.97M | 减持 |
| Q3 2026 | 445.25K | $37.39M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HSIC 与 13F 数据
HSIC(SCHEIN HENRY INC)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 HSIC,申报仓位最大的包括:Kohlberg Kravis Roberts & Co. L.P. (US$1.31B), Artisan Partners Limited Partnership (US$462.3M), Southpoint Capital Advisors LP (US$275.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HSIC 的基金
- Kohlberg Kravis Roberts & Co. L.P. 15.65M 股 · $1.31B · Q3 2026
- Artisan Partners Limited Partnership 5.51M 股 · $462.30M · Q3 2026
- Southpoint Capital Advisors LP 3.30M 股 · $275.62M · Q2 2026
- Palestra Capital Management LLC 2.45M 股 · $204.35M · Q2 2026
- LYRICAL ASSET MANAGEMENT LP 1.50M 股 · $126.34M · Q3 2026
- M.D. Sass, LLC 1.29M 股 · $107.49M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 1.29M 股 · $107.34M · Q2 2026
更多关于 THOMPSON SIEGEL & WALMSLEY LLC
常见问题
How long has THOMPSON SIEGEL & WALMSLEY LLC held HSIC?
THOMPSON SIEGEL & WALMSLEY LLC has disclosed HSIC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is THOMPSON SIEGEL & WALMSLEY LLC's current position in HSIC?
As of Q3 2026, THOMPSON SIEGEL & WALMSLEY LLC holds 445.25K shares of HSIC (SCHEIN HENRY INC), valued at $37.39M, representing 0.70% of its reported portfolio and ranking #48.
Has THOMPSON SIEGEL & WALMSLEY LLC been buying or selling HSIC?
In the latest 13F filing (Q3 2026), THOMPSON SIEGEL & WALMSLEY LLC reduced its position in HSIC. The position peaked in Q3 2024 at 1.00M shares.
Which other funds hold HSIC?
Other major institutional holders of HSIC include Kohlberg Kravis Roberts & Co. L.P., Artisan Partners Limited Partnership, Southpoint Capital Advisors LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.